patent expiration

OSPHENA (ospemifene) Duchesnay Patent: 9,855,224 Expiration: Feb 13, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug Pa…

Annual Drug Patent Expirations for INJECTAFER Injectafer is a drug marketed by Am Regent and is included in one NDA. It is available from one supplier. There are ten patents…
The post New patent expiration for Am Regent drug INJECTAFER appeared first o…

NATESTO (testosterone) Acerus Patent: 8,784,869 Expiration: Feb 4, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug Pate…

Annual Drug Patent Expirations for NATESTO Natesto is a drug marketed by Acerus and is included in one NDA. It is available from one supplier. There are five patents protecting…
The post New patent expiration for Acerus drug NATESTO appeared first on D…

NATESTO (testosterone) Acerus Patent: 8,877,230 Expiration: Feb 4, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug Pate…

Annual Drug Patent Expirations for ORGOVYX Orgovyx is a drug marketed by Sumitomo Pharma and is included in one NDA. It is available from one supplier. There are eight patents…
The post New patent expiration for Sumitomo Pharma drug ORGOVYX appeared fi…

Annual Drug Patent Expirations for EVOCLIN Evoclin is a drug marketed by Mylan and is included in one NDA. There are two patents protecting this drug and one Paragraph IV…
The post New patent expiration for MYLAN drug EVOCLIN appeared first on DrugPate…

Annual Drug Patent Expirations for NOCDURNA Nocdurna is a drug marketed by Ferring Pharms Inc and is included in one NDA. It is available from one supplier. There are ten…
The post New patent expiration for Ferring Pharms drug NOCDURNA appeared first o…

Annual Drug Patent Expirations for CHLORAPREP+WITH+TINT Chloraprep With Tint is a drug marketed by Becton Dickinson Co and is included in one NDA. It is available from two suppliers. There…
The post New patent expiration for Becton Dickinson drug CHLOR…

Annual Drug Patent Expirations for CHLORAPREP+ONE-STEP Chloraprep One-step is a drug marketed by Becton Dickinson Co and is included in two NDAs. It is available from two suppliers. There are…
The post New patent expiration for Becton Dickinson drug CH…